Bo Chen
Shenyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Corrigendum: Combination of rapamycin and MK-2206 induced cell death via autophagy and necroptosis in MYCN-amplified neuroblastoma cell lines.
Journal: Frontiers in pharmacology
Published: April 29, 2024
SESN1 functions as a new tumor suppressor gene via Toll-like receptor signaling pathway in neuroblastoma.
Journal: CNS neuroscience & therapeutics
Published: December 15, 2023
Comprehensive analysis and validation reveal potential MYCN regulatory biomarkers associated with neuroblastoma prognosis.
Journal: Journal of biomolecular structure & dynamics
Published: October 27, 2022
The incidence, prevalence, and survival analysis of pancreatic neuroendocrine tumors in the United States.
Journal: Journal of endocrinological investigation
Published: May 07, 2022
Correction to: Downregulation of fibronectin 1 attenuates ATRA‑induced inhibition of cell migration and invasion in neuroblastoma cells.
Journal: Molecular and cellular biochemistry
Published: February 28, 2022
Downregulation of fibronectin 1 attenuates ATRA-induced inhibition of cell migration and invasion in neuroblastoma cells.
Journal: Molecular and cellular biochemistry
Published: December 08, 2020
Integrated Microarray to Identify the Hub miRNAs and Constructed miRNA-mRNA Network in Neuroblastoma Via Bioinformatics Analysis.
Journal: Neurochemical research
Published: August 10, 2020
Analysis and identification of novel biomarkers involved in neuroblastoma via integrated bioinformatics.
Journal: Investigational new drugs
Published: June 15, 2020
Combination of Rapamycin and MK-2206 Induced Cell Death via Autophagy and Necroptosis in MYCN-Amplified Neuroblastoma Cell Lines.
Journal: Frontiers in pharmacology
Published: November 04, 2019
Showing 1-10 of 10
Last Updated: 09/26/2026